[Bone loss induced by GnRH agonist treatment]

Nihon Rinsho. 2004 Feb:62 Suppl 2:702-5.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / adverse effects
  • Bone Density / drug effects
  • Bone Resorption / chemically induced*
  • Bone Resorption / metabolism
  • Bone Resorption / prevention & control
  • Diphosphonates / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Leuprolide / administration & dosage
  • Leuprolide / adverse effects*
  • Medroxyprogesterone Acetate / administration & dosage
  • Selective Estrogen Receptor Modulators / administration & dosage

Substances

  • Antineoplastic Agents, Hormonal
  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Gonadotropin-Releasing Hormone
  • Medroxyprogesterone Acetate
  • Leuprolide